Cancer Gene Therapy Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

Report Code: HCR 53831 Report Format: PDF + Excel (Delivery in 48 Hrs)
1. Cancer Gene Therapy Market - Overview
        1.1 Definitions and Scope
2. Cancer Gene Therapy Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Cancer Gene Therapy Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Cancer Gene Therapy Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Cancer Gene Therapy Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Cancer Gene Therapy Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Cancer Gene Therapy Market - Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Cancer Gene Therapy Market - By Product (Market Size -$Million / $Billion)
9. Cancer Gene Therapy Market - By Therapy (Market Size -$Million / $Billion)
        9.1 Oncolytic Virotherapy
            9.1.1 Adenovirus
            9.1.2 Lentivirus
            9.1.3 Retro Virus
            9.1.4 Adeno Associated Virus
            9.1.5 Herpes Simplex Virus
            9.1.6 Alpha Virus
            9.1.7 Vaccinia Virus
            9.1.8 Simian Virus
        9.2 Gene Transfer
            9.2.1 Naked Plasmid Vector
            9.2.2 Electroporation
            9.2.3 Sonoportion
            9.2.4 Magnetofection
            9.2.5 Gene Gun
        9.3 Gene-Induced Immunotherapy
            9.3.1 Delivery Of Cytokine Gene
            9.3.2 Delivery Of Tumor Antigen Gene
10. Cancer Gene Therapy - By Application (Market Size -$Million / $Billion)
11. Cancer Gene Therapy - By Geography (Market Size -$Million / $Billion)
        11.1 Cancer Gene Therapy Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Cancer Gene Therapy- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Cancer Gene Therapy- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Cancer Gene Therapy - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Cancer Gene Therapy - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Cancer Gene Therapy Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Cancer Gene Therapy Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Cancer Gene Therapy Market - Key Company List by Country Premium
15. Cancer Gene Therapy Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Biocancell
        15.3 Bluebird Bio, Inc
        15.4 Celgene
        15.5 Glaxosmithkline
        15.6 Merck
        15.7 Oncogenex Pharmaceutical
        15.8 Shanghai Sunway Biotech
        15.9 Shenzhen Sibiono Genetech
        15.10 Synergene Therapeutic
        15.11 Company 11
        15.12 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Cancer Gene Therapy Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Cancer Gene Therapy Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Cancer Gene Therapy Market, By Therapy Market 2019-2024 ($M)
1.2 Gene Transfer Market 2019-2024 ($M) - Global Industry Research
1.2.1 Naked Plasmid Vector Market 2019-2024 ($M)
1.2.2 Electroporation Market 2019-2024 ($M)
1.2.3 Sonoportion Market 2019-2024 ($M)
1.2.4 Magnetofection Market 2019-2024 ($M)
1.2.5 Gene Gun Market 2019-2024 ($M)
2.Global Cancer Gene Therapy Market, By Therapy Market 2019-2024 (Volume/Units)
2.2 Gene Transfer Market 2019-2024 (Volume/Units) - Global Industry Research
2.2.1 Naked Plasmid Vector Market 2019-2024 (Volume/Units)
2.2.2 Electroporation Market 2019-2024 (Volume/Units)
2.2.3 Sonoportion Market 2019-2024 (Volume/Units)
2.2.4 Magnetofection Market 2019-2024 (Volume/Units)
2.2.5 Gene Gun Market 2019-2024 (Volume/Units)
3.North America Cancer Gene Therapy Market, By Therapy Market 2019-2024 ($M)
3.2 Gene Transfer Market 2019-2024 ($M) - Regional Industry Research
3.2.1 Naked Plasmid Vector Market 2019-2024 ($M)
3.2.2 Electroporation Market 2019-2024 ($M)
3.2.3 Sonoportion Market 2019-2024 ($M)
3.2.4 Magnetofection Market 2019-2024 ($M)
3.2.5 Gene Gun Market 2019-2024 ($M)
4.South America Cancer Gene Therapy Market, By Therapy Market 2019-2024 ($M)
4.2 Gene Transfer Market 2019-2024 ($M) - Regional Industry Research
4.2.1 Naked Plasmid Vector Market 2019-2024 ($M)
4.2.2 Electroporation Market 2019-2024 ($M)
4.2.3 Sonoportion Market 2019-2024 ($M)
4.2.4 Magnetofection Market 2019-2024 ($M)
4.2.5 Gene Gun Market 2019-2024 ($M)
5.Europe Cancer Gene Therapy Market, By Therapy Market 2019-2024 ($M)
5.2 Gene Transfer Market 2019-2024 ($M) - Regional Industry Research
5.2.1 Naked Plasmid Vector Market 2019-2024 ($M)
5.2.2 Electroporation Market 2019-2024 ($M)
5.2.3 Sonoportion Market 2019-2024 ($M)
5.2.4 Magnetofection Market 2019-2024 ($M)
5.2.5 Gene Gun Market 2019-2024 ($M)
6.APAC Cancer Gene Therapy Market, By Therapy Market 2019-2024 ($M)
6.2 Gene Transfer Market 2019-2024 ($M) - Regional Industry Research
6.2.1 Naked Plasmid Vector Market 2019-2024 ($M)
6.2.2 Electroporation Market 2019-2024 ($M)
6.2.3 Sonoportion Market 2019-2024 ($M)
6.2.4 Magnetofection Market 2019-2024 ($M)
6.2.5 Gene Gun Market 2019-2024 ($M)
7.MENA Cancer Gene Therapy Market, By Therapy Market 2019-2024 ($M)
7.2 Gene Transfer Market 2019-2024 ($M) - Regional Industry Research
7.2.1 Naked Plasmid Vector Market 2019-2024 ($M)
7.2.2 Electroporation Market 2019-2024 ($M)
7.2.3 Sonoportion Market 2019-2024 ($M)
7.2.4 Magnetofection Market 2019-2024 ($M)
7.2.5 Gene Gun Market 2019-2024 ($M)

LIST OF FIGURES

1.US Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
2.Canada Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
3.Mexico Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
4.Brazil Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
5.Argentina Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
6.Peru Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
7.Colombia Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
8.Chile Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
9.Rest of South America Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
10.UK Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
11.Germany Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
12.France Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
13.Italy Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
14.Spain Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
15.Rest of Europe Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
16.China Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
17.India Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
18.Japan Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
19.South Korea Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
20.South Africa Cancer Gene Therapy Market Revenue, 2019-2024 ($M)
21.North America Cancer Gene Therapy By Application
22.South America Cancer Gene Therapy By Application
23.Europe Cancer Gene Therapy By Application
24.APAC Cancer Gene Therapy By Application
25.MENA Cancer Gene Therapy By Application
26.Glaxosmithkline, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Bluebird Bio, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Merck, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Celgene, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Shanghai Sunway Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Biocancell, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Shenzhen Sibiono Genetech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Synergene Therapeutic, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Oncogenex Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)